CD28 抗体
Quick Overview for CD28 抗体 (ABIN6961446)
抗原
See all CD28 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
交叉反应
- Baboon, Chimpanzee, Cynomolgus, 猕猴
-
纯化方法
- This monoclonal antibody preparation was purified from tissue culture supernatant via affinity chromatography. For In Vivo Ready™ (IVR) products, each preparation is also evaluated for endotoxin levels using the LAL assay. It is recommended to store the product undiluted at 4°C. Do not freeze.
-
内毒素水平
- Low endotoxin: < 0.01 EU/ug
-
亚型
- IgG1 kappa
-
-
-
-
应用备注
- This purified format is guaranteed to be >90 % pure as determined by SDS-PAGE analysis.
-
说明
-
2 mg/mL
-
限制
- 仅限研究用
-
-
-
缓冲液
- 10 mM NaH2PO4, 150 mM NaCl, pH 7.2
-
储存液
- Azide free
-
储存条件
- 4 °C
-
储存方法
- 2-8°C
-
有效期
- 12 months
-
-
- CD28
-
别名
- CD28
-
背景
- The CD28.2 antibody reacts with human CD28, a 44 kDa type I surface glycoprotein which acts as a co-stimulatory receptor in support of the T cell receptor (TCR). CD28 exists as a homodimer with specificity for two known ligands, known as B7-1 (CD80) and B7-2 (CD86), which are expressed on activated B cells and antigen-presenting cells. These ligands trigger CD28 signaling in concert with TCR activa- tion to drive T cell proliferation, induce high-level expression of IL-2, impart resistance to apoptosis, and enhance T cell cytotoxicity. The interaction / co-stimulatory signaling between the B7 ligands and CD28 provides crucial communication between T cells and B cells or APCs to coordinate the adaptive immune response. Other members of the CD28 family of receptors include CTLA-4 (CD152), PD-1 (CD279), ICOS and BTLA.The CD28.2 antibody may be used as a phenotypic marker for human CD28, expressed on all CD4+ T cells and CD8+ T cells, and is widely used as a reagent for activation of the CD28 receptor in vitro and in vivo. This antibody is also reported to be cross-reactive with several non-human species, including Baboon, Chimpanzee, Cynomolgus, and Rhesus.
-
基因ID
- 940
-
UniProt
- P10747
-
途径
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
抗原
-